Resources Contact Us Home
Metal/metal oxide doped oxide catalysts having high deNOx selectivity for lean NOx exhaust aftertreatment systems

Image Number 3 for United States Patent #6706660.

A lean NOx catalyst and method of preparing the same is disclosed. The lean NOx catalyst includes a ceramic substrate, an oxide support material, preferably .gamma.-alumina, deposited on the substrate and a metal promoter or dopant introduced into the oxide support material. The metal promoters or dopants are selected from the group consisting of indium, gallium, tin, silver, germanium, gold, nickel, cobalt, copper, iron, manganese, molybdenum, chromium, cerium, vanadium, oxides thereof, and combinations thereof. The .gamma.-alumina preferably has a pore volume of from about 0.5 to about 2.0 cc/g; a surface area of between about 80 to 350 m.sup.2 /g; an average pore size diameter of between about 3 to 30 nm; and an impurity level of less than or equal to 0.2 weight percent. In a preferred embodiment the .gamma.-alumina is prepared by a sol-gel method, with the metal doping of the .gamma.-alumina preferably accomplished using an incipient wetness impregnation technique.

  Recently Added Patents
Rule-based stimulation program search
Method and device for generating low-jitter clock
Cantilevered probe detector with piezoelectric element
Optoelectronic devices and a method for producing the same
Apparatus for merging spatial audio streams
Systems, methods and apparatus for payment processing
Therapeutic compositions and methods
  Randomly Featured Patents
Method and apparatus for measuring the temperature of a gas in a mass flow controller
MR imaging method and apparatus with water signal supression
Vacuum cleaning apparatus
Semiconductor device and SRAM having plural power supply voltages
Diffractive optical device, and aligner comprising that device
Multi-purpose decorating machine
Pantropic neurothrophic factors
Carpet using unused yarn
Electronic quantity purchasing system
Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring